MLXIPL and Hepatic steatosis: A previous study showed that the ChREBP is a regulatory center of adipogenesis in vivo and plays a decisive role in developing hepatic steatosis and IR; the specific inhibition of the ChREBP significantly improves hepatic steatosis in ob/ob mice [66].